vTv Therapeutics Inc. VTVT announced today the
pricing of its initial public offering of 7,812,500 shares of its Class
A common stock at a price to the public of $15.00 per share. All of the
shares are being offered by the Company. In addition, the Company has
granted the underwriters an option to purchase up to an additional
1,171,875 shares of Class A common stock. The shares of Class A common
stock are expected to begin trading on the Nasdaq Global Market on July
30, 2015, under the symbol "VTVT."
The Company intends to use the net proceeds of the offering to fund the
STEADFAST Study (its ongoing Phase 3 trial of azeliragon, a drug
candidate for
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in